Journal of the National Medical Association · 2016
Cholesterol Levels in Patients with Chronic Lymphocytic Leukemia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yavasoglu Irfan, Sargin Gokhan, Yilmaz Fergun, Altındag Sermin, Akgun Gulsum, Tombak Anil, Toka Bila, Dal Sinan, Ozbas Hasan, Cetin Guven, Donmez Ayhan, Yegin Zeynep Arzu, Bilgir Oktay, Tiftik Naci, Ertop Sehmus, Ayyildiz Orhan, Sonmez Mehmet, Pektas Gokhan, Kadıkoylu Gurhan, Tombuloglu Murat, Bolaman Zahit
Аннотация
Low cholesterol levels may be accompanied by solid tumors or hematological malignancies such as multiple myeloma. Decreased cholesterol levels have been reported in some experimental studies about chronic lymphocytic leukemia (CLL). It may be associated with tumoral cell metabolism. Herein, we examine blood lipid profiles of patients with newly diagnosed CLL (284 male, 276 female, mean age 64 ± 11 years) as defined by National Cancer Institute criteria. The control group consisted of 71 healthy subjects with mean age 55 ± 9 years (28 male, 43 females). 60% of patients with Binet A, while 25% were Binet C. Decreased levels of total cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL) were observed in patients with CLL than control group (p < 0,001). There was no statistical significance between CLL and control group for triglycerides (TG) and very low density lipoprotein (VLDL), also between HDL-C, VLDL, TG and grades. Cholesterol may metabolized by abnormal lymphocytes in CLL patients.